General

Anniversary: Serving our clients for 15 years

Sylics was founded in February 2007, as spin-off company of the VU University in Amsterdam. In the first few years, Sylics performed behavioural screening of new mouse mutants in several ...

Sylics’ new website online

The portfolio of mouse models and CRO services of Sylics has grown over the last decade. To accomodate this expansion we have updated our website. This should help our clients ...

Sylics starts-up a new location to expand our services and to support your CNS disease research

The ongoing COVID-19 pandemic and again rising infection numbers is affecting all of us personally and our businesses. In this situation, Sylics is focused to continue and expand our support ...

Sylics stands for efficient and high quality drug screening

Tight timelines? Are you in need to have a drug screening study finished before the end of the year to comply with deadlines or your annual budget? At Sylics, we ...

Relevant autism and mental retardation related changes in the Fmr1 knockout mouse

In humans, the absence of the FMR1 protein leads to Fragile X syndrome, mental retardation and neurodevelopmental delays. The Fmr1 knockout mouse model is perceived as highly translational relevant due to the ...

The 22q11 mouse model available at Sylics shows robust Schizophrenia-relevant deficits

Sylics characterized an accepted model in the field of schizophrenia research based on a microdeletion in the orthologous human 22q11.2 locus. In humans, a microdeletion of the 22q11.2 locus leads ...

Sylics is comitted to support CNS disease research, also during these challenging times

The outbreak of COVID-19 affects all of us worldwide in an unprecedented manner. This requires us all to prioritize care and take disruptive measures to stop spread of the virus. ...

Mouse models: Alzheimer’s disease and seeding of tau pathology

An Alzheimer’s Disease mouse model induced by ‘seeding’ of tau pathology may more closely mimic human tau pathology in comparison to transgenic tauopathy mouse models that overexpress human tau with ...

Updated privacy policy

In order to comply with the new GDPR regulation, Sylics has updated it’s privacy statement to give a clear overview of which personal data is used for what reason. You ...

Sylics receives certificate for “Good Research Practice”

We are proud to announce that Sylics received the “Good Research Practice” certificate (PAASPort) from Partnership for Assessment and Accreditation of Scientific Practice (PAASP). Robustness of preclinical data is the ...

Stay up-to-date

Sign up for our newsletter and stay up-to-date with the latest news and publications

Pellentesque varius massa vitae aliquet tristique.

Pellentesque varius massa vitae aliquet tristique.

Pellentesque varius massa vitae aliquet tristique.

Please enter your name.
Please enter a message.